Printer Friendly

Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.

RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the Thomas Weisel Partners 2005 Healthcare Conference in Boston, MA on Thursday, September 8 at 9:10 a.m. ET.

Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's 100-member gastroenterology specialty sales and marketing team. Salix markets COLAZAL(R), XIFAXAN(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). A granulated mesalamine product also is under development. Salix trades on the Nasdaq National Market under the ticker symbol "SLXP".

For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 1, 2005
Words:182
Previous Article:Health Dialog Executive to Speak at the Second Annual Health Information Technology Summit.
Next Article:Systech and Certegy Announce IP-based Check Processing Solution; Certegy to Roll-out New, IP Services Based on Systech Dial-to-IP Converter.
Topics:


Related Articles
Corixa to Present at Biocentury Newsmakers and Thomas Weisel Partners Healthcare Conferences.
Depomed Prices Public Offering at $5.50 Per Share.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
Monster Worldwide to Present at Thomas Weisel Partners' Internet 2005 Conference and at the 33rd Annual JP Morgan Technology Conference.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
First Horizon to Present at the 2005 Thomas Weisel Partners Health Care Conference.
Salix Pharmaceuticals to Present at Roth Capital Partners Conference.
NutriSystem, Inc. to Present at Thomas Weisel Partners and Smith Barney New York Conferences.
Ionatron to Present at Thomas Weisel Partners Security Technology Conference 2005.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters